Kimberly-Clark (NYSE:KMB - Get Free Report) was downgraded by research analysts at StockNews.com from a "buy" rating to a "hold" rating in a report released on Wednesday.
Several other equities analysts have also recently weighed in on KMB. Citigroup lowered their price objective on shares of Kimberly-Clark from $125.00 to $118.00 and set a "sell" rating on the stock in a research note on Wednesday, January 15th. Royal Bank of Canada reiterated an "outperform" rating and set a $165.00 price target on shares of Kimberly-Clark in a research note on Friday, January 24th. Wells Fargo & Company reduced their price objective on Kimberly-Clark from $140.00 to $130.00 and set an "equal weight" rating for the company in a research note on Tuesday, January 7th. Deutsche Bank Aktiengesellschaft lifted their target price on Kimberly-Clark from $146.00 to $147.00 and gave the company a "hold" rating in a research report on Tuesday, October 8th. Finally, JPMorgan Chase & Co. decreased their price objective on Kimberly-Clark from $140.00 to $124.00 and set an "underweight" rating on the stock in a research note on Thursday, January 16th. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $143.64.
Check Out Our Latest Stock Report on Kimberly-Clark
Kimberly-Clark Stock Performance
Kimberly-Clark stock traded up $0.23 during midday trading on Wednesday, reaching $129.67. 1,881,103 shares of the company traded hands, compared to its average volume of 2,081,561. Kimberly-Clark has a 12 month low of $117.67 and a 12 month high of $149.30. The company has a debt-to-equity ratio of 4.77, a current ratio of 0.83 and a quick ratio of 0.55. The business has a 50 day moving average of $131.63 and a two-hundred day moving average of $137.41. The firm has a market capitalization of $43.24 billion, a price-to-earnings ratio of 16.82, a price-to-earnings-growth ratio of 3.53 and a beta of 0.41.
Kimberly-Clark (NYSE:KMB - Get Free Report) last released its quarterly earnings results on Tuesday, January 28th. The company reported $1.50 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $1.50. Kimberly-Clark had a return on equity of 198.59% and a net margin of 12.97%. As a group, research analysts predict that Kimberly-Clark will post 7.32 earnings per share for the current year.
Insider Activity
In other news, VP Andrew Drexler sold 3,000 shares of the stock in a transaction that occurred on Friday, November 22nd. The stock was sold at an average price of $139.01, for a total transaction of $417,030.00. Following the completion of the transaction, the vice president now directly owns 5,053 shares in the company, valued at approximately $702,417.53. This represents a 37.25 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.62% of the company's stock.
Institutional Investors Weigh In On Kimberly-Clark
A number of hedge funds have recently bought and sold shares of the business. Migdal Insurance & Financial Holdings Ltd. purchased a new position in Kimberly-Clark in the fourth quarter worth about $25,000. Darwin Wealth Management LLC purchased a new position in shares of Kimberly-Clark in the 3rd quarter worth approximately $29,000. DiNuzzo Private Wealth Inc. raised its holdings in Kimberly-Clark by 808.0% during the 3rd quarter. DiNuzzo Private Wealth Inc. now owns 227 shares of the company's stock valued at $32,000 after buying an additional 202 shares during the period. Golden State Wealth Management LLC bought a new stake in Kimberly-Clark in the fourth quarter worth $32,000. Finally, Strategic Financial Concepts LLC bought a new position in Kimberly-Clark during the fourth quarter valued at $33,000. Hedge funds and other institutional investors own 76.29% of the company's stock.
Kimberly-Clark Company Profile
(
Get Free Report)
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Kimberly-Clark, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kimberly-Clark wasn't on the list.
While Kimberly-Clark currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.